Just a moment, the page is loading...

CRUK-CCR3086, REC 08/H0903/40




HOT-II: Randomised double-blind controlled phase III trial of hyperbaric oxygen therapy in patients suffering long-term adverse effects of radiotherapy for pelvic cancer
Hyperbaric Oxygen
CCR3086, REC 08/H0903/40
NCT01087268
Pelvic cancer
Phase 3
 
July 2019